Net Worth Advisory Group’s Novo Nordisk NVO Stock Holding History

Net Worth Advisory Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Sell	6,216 -853	-12%	-$36.6K	0.08%	287
2026 Q1	$260K	Buy	7,069 +2,628	+59%	+$125K	0.05%	347
2025 Q4	$226K	Sell	4,441 -1,816	-29%	-$92.9K	0.05%	405
2025 Q3	$347K	Sell	6,257 -1,128	-15%	-$66K	0.1%	230
2025 Q2	$510K	Buy	7,385 +1,605	+28%	+$109K	0.11%	191
2025 Q1	$401K	Sell	5,780 -31	-0.5%	-$2.56K	0.13%	188
2024 Q4	$500K	Sell	5,811 -243	-4%	-$26.3K	0.15%	175
2024 Q3	$721K	Buy	+6,054	New	+$807K	0.21%	113

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Net Worth Advisory Group's NVO Position: Q2 2026 in Review

Net Worth Advisory Group reduced its Novo Nordisk (NVO) stake by 12% in Q2 2026, selling an estimated $36.6K and leaving 6,216 shares worth $298K. The position accounts for 0.08% of the portfolio, ranked #287.

Net Worth Advisory Group first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $721K in Q3 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Net Worth Advisory Group held 6,216 shares of Novo Nordisk worth $298K as of Q2 2026.
Net Worth Advisory Group sold 853 Novo Nordisk shares in Q2 2026, an estimated $36.6K.
Novo Nordisk made up 0.08% of Net Worth Advisory Group's portfolio in Q2 2026, its #287 holding.
Net Worth Advisory Group first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
Net Worth Advisory Group's Novo Nordisk position peaked at $721K in Q3 2024.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.